Evidence map›Paper›PMID 36242969›Full record

ReviewPathology, research and practice2022

Beyond COVID-19 and SARS-CoV-2, cardiovascular outcomes of "long covid" from a pathological perspective - a look back and road ahead.

Durre Aden, Sufian Zaheer, Rohit Kumar, Swati Raj, Taiba Khan, Shilpi Varshney

Open access · greenAbstract readReview
In one paragraph

Review in Pathology, research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Durre AdenDepartment of Pathology, HIMSR, Jamia Hamdard, New Delhi, India.
Sufian ZaheerDepartment of Pathology, VMMC and Safdarjang Hospital, New Delhi, India. Electronic address: Sufianzaher@gmail.com.
Rohit KumarDepartment of Pulmonary Medicine, Critical Care Medicine and Sleep Disorders, VMMC and Safdarjang Hospital, New Delhi, India.
Swati RajGovernment Doon Medical College, Dehradun, Uttarakhand, India.
Taiba KhanLab Medicine, Jaypee Hospital, Noida, India.
Shilpi VarshneySiddh Hospital, Moradabad, India.
Safdarjang Hospital · INDoon University · INJamia Hamdard · INJaypee Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the decrease in severity of COVID-19 there is a sense of relief in the general population. However, there has been an increased incidence of cardiovascular and other organ complications post-infection, which have raised concerns about long COVID. The term "long COVID" was first used by Perego on social media to denote the persistence of symptoms weeks or months after initial SARS-CoV-2 infection and the term 'long haulers' was first described by Watson and by Yong to identify post-COVID conditions. There has been an increased incidence of sudden cardiac death and MI post-COVID-19 in healthy individuals, sports persons and prominent movie stars. Potential mechanisms contributing to the pathophysiology of post-acute COVID-19 may include 1) Damage to tissues and cells that are important for blood flow, so clotting of blood is increased. 2) Persistence of fragments of virus or its sub-particles/ protein material in a wide range of body sites and, 3) an immune system gone haywire. As the majority of countries across the globe are easing coronavirus precautionary measures, there is an urgent need by health care organizations and policymakers worldwide to generate awareness by educating the public at large, about the ill effects of long-COVID and varied types of post-acute sequelae of COVID-19.

Indexed as

COVID-19SARS-CoV-2HumansLungPost-Acute COVID-19 SyndromeCOVID-19Long-COVIDMyocarditisPost-acute sequelae of COVID-19

Identifiers

PMID36242969
PMCPMC9519512
OpenAlexW4298003062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.